Back to results
US 2006/0040854 A1Published application
Prostate hyperplasia therapy
AssigneeBoard of Regents, The University of Texas System
InventorLuis Parada
Life of this patent
Estimating the term…
Abstract
The invention is a method for treating prostate hyperplasia by contacting a patient with insulin-6 in an amount effective to prevent or reduce prostate hyperplasia. The invention includes transgenic insulin-6 knockout mice that exhibit prostate hyperplasia and that can be used in screening agents for anti-prostate hyperplasia activity.
Claims10
1-8. (canceled)
A method of determining whether a human patient determined to be subject to or predisposed to prostate hyperplasia patient underexpresses insulin-6, the method comprising the steps of:
- obtaining a biological sample from the patient and testing the sample for abnormal, insulin-6 underexpression expression relative to a control.
10-11. (canceled)
Dependencies are inferred from the claim text.